No definition available.
Melanocytic naevi of other and unspecified parts of face
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_MELANOCYTIC_FACE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2068 |
4. Check minimum number of eventsNone |
2068 |
5. Include endpointsNone |
2068 |
6. Filter based on genotype QC (FinnGen only) |
1995 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Similar endpoints
↥List of similar endpoints to Melanocytic naevi of other and unspecified parts of face based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi of other and unspecified parts of face
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 16215 | 10654 | 5504 |
Only index persons | 15389 | 10225 | 5164 |
Unadjusted period prevalence (%) | |||
Whole population | 0.25 | 0.31 | 0.15 |
Only index persons | 0.32 | 0.38 | 0.20 |
Median age at first event (years) | |||
Whole population | 44.36 | 44.13 | 44.75 |
Only index persons | 44.23 | 43.97 | 44.75 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 1995 | 1400 | 595 |
Unadjusted period prevalence (%) | 0.47 | 0.55 | 0.30 |
Median age at first event (years) | 48.62 | 45.22 | 56.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MELANOCYTIC_FACE and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_MELANOCYTIC_FACE | 0.859 [0.77, 0.96] | 0.009 |
Birth year | 0.997 [0.99, 1.01] | 0.513 |
During the follow-up period (1.1.1998 — 31.12.2019), 755 out of 8978 females with CD2_BENIGN_MELANOCYTIC_FACE died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_MELANOCYTIC_FACE | 0.856 [0.76, 0.97] | 0.013 |
Birth year | 0.993 [0.98, 1.0] | 0.108 |
During the follow-up period (1.1.1998 — 31.12.2019), 590 out of 4616 males with CD2_BENIGN_MELANOCYTIC_FACE died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MELANOCYTIC_FACE.N-year risk | Females | Males |
---|---|---|
1 | 0.072% | 0.191% |
5 | 0.436% | 1.109% |
10 | 1.176% | 2.921% |
15 | 2.395% | 5.773% |
20 | 4.597% | 9.912% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_FACE – Melanocytic naevi of other and unspecified parts of face
GWS hits: -